120 related articles for article (PubMed ID: 21492921)
1. Prognostic significance of DNA ploidy in stage I endometrial cancer.
Song T; Lee JW; Kim HJ; Kim MK; Choi CH; Kim TJ; Bae DS; Kim BG
Gynecol Oncol; 2011 Jul; 122(1):79-82. PubMed ID: 21492921
[TBL] [Abstract][Full Text] [Related]
2. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
3. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.
Santala M; Talvensaari-Mattila A
Anticancer Res; 2003; 23(6D):5191-6. PubMed ID: 14981988
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of DNA ploidy and S-phase fraction in endometrial cancer stage I and II: a prospective 5-year survival study.
Friberg LG; Norén H; Delle U
Gynecol Oncol; 1994 Apr; 53(1):64-9. PubMed ID: 8175025
[TBL] [Abstract][Full Text] [Related]
8. The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.
Nordal RR; Kristensen GB; Kaern J; Stenwig AE; Pettersen EO; Tropé CG
Gynecol Oncol; 1996 Aug; 62(2):254-9. PubMed ID: 8751558
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DNA ploidy in endometrial cancer.
Ikeda M; Watanabe Y; Nanjoh T; Noda K
Gynecol Oncol; 1993 Jul; 50(1):25-9. PubMed ID: 8349160
[TBL] [Abstract][Full Text] [Related]
10. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
Bell JG; Minnick A; Reid GC; Judis J; Brownell M
Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
[TBL] [Abstract][Full Text] [Related]
11. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
12. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
13. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.
Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H
Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
15. [Flow cytometric evaluation of DNA ploidy pattern in uterine cancer].
Watanabe T; Izumi S; Yamaoka K; Tsutsui F; Nozawa S
Nihon Rinsho; 1992 Oct; 50(10):2432-8. PubMed ID: 1447814
[TBL] [Abstract][Full Text] [Related]
16. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer].
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometry as a prognostic factor in endometrial cancer--what does it add?
Braly PS
Gynecol Oncol; 1995 Aug; 58(2):145-7. PubMed ID: 7622097
[No Abstract] [Full Text] [Related]
18. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
19. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
[TBL] [Abstract][Full Text] [Related]
20. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
